Dov Gavish

3.9k total citations · 1 hit paper
70 papers, 2.7k citations indexed

About

Dov Gavish is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dov Gavish has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dov Gavish's work include Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Cardiovascular Health and Disease Prevention (10 papers). Dov Gavish is often cited by papers focused on Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Cardiovascular Health and Disease Prevention (10 papers). Dov Gavish collaborates with scholars based in Israel, United States and United Kingdom. Dov Gavish's co-authors include J L Breslow, S Eisenberg, Y Oschry, Neal Azrolan, Marina Shargorodsky, M Fainaru, Eyal Leibovitz, Richard J. Deckelbaum, Mona Boaz and Gerhard M. Kostner and has published in prestigious journals such as Science, The Lancet and Nucleic Acids Research.

In The Last Decade

Dov Gavish

69 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

2000 563 citations Dov Gavish et al. profile →

Peers

Dov Gavish

SURGE

EDM

CCM

HEMAT

Gösta Dahlén Sweden

Stephen Pyke United Kingdom

Francesco Dati Germany

Danish Saleheen Pakistan

Jeong Yeal Ahn South Korea

Mieke D. Trip Netherlands

Jean‐Pierre Cambou France

Roberto Marchioli Italy

Marina Camera Italy

Jürgen Meyer Germany

Gösta Dahlén Sweden

Dov Gavish

1.3k ×1.1

SURGE

960 ×1.2

EDM

852 ×1.2

CCM

532 ×1.1

HEMAT

766 ×2.0

Citations per year, relative to Dov Gavish Dov Gavish (= 1×) peers Gösta Dahlén

Countries citing papers authored by Dov Gavish

Since Specialization

Citations

This map shows the geographic impact of Dov Gavish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dov Gavish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dov Gavish more than expected).

Fields of papers citing papers by Dov Gavish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dov Gavish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dov Gavish. The network helps show where Dov Gavish may publish in the future.

Co-authorship network of co-authors of Dov Gavish

This figure shows the co-authorship network connecting the top 25 collaborators of Dov Gavish. A scholar is included among the top collaborators of Dov Gavish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dov Gavish. Dov Gavish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yosefy, Chaim, et al.. (2016). [THE IMPACT OF A COMMUNITY INTERVENTION PROGRAM IN ISRAELI WORKSITES TO REDUCE THE RISK OF CARDIOVASCULAR DISEASES].. PubMed. 155(8). 485–489. 2 indexed citations

Durst, Ronen, Shoshi Shpitzen, Daniel Schurr, et al.. (2016). Molecular genetics of familial hypercholesterolemia in Israel–revisited. Atherosclerosis. 257. 55–63. 17 indexed citations

Gavish, Dov, et al.. (2014). Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease. Journal of the American Society of Hypertension. 8(6). 376–380. 13 indexed citations

Shargorodsky, Marina, et al.. (2012). Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?. Cardiovascular Diabetology. 11(1). 61–61. 42 indexed citations

Maccubbin, Darbie, Michael J. Koren, Michael Davidson, et al.. (2009). Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease. The American Journal of Cardiology. 104(1). 74–81. 57 indexed citations

Shargorodsky, Marina, et al.. (2009). Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?. International Journal of Obesity. 33(5). 553–558. 55 indexed citations

Boaz, Mona, et al.. (2008). Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors. Bone. 43(2). 279–283. 13 indexed citations

Shargorodsky, Marina, et al.. (2008). Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. Atherosclerosis. 204(2). 608–611. 35 indexed citations

Boaz, Mona, et al.. (2008). Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients. Atherosclerosis. 199(2). 362–367. 18 indexed citations

10.

Yosefy, Chaim, Gary Ginsberg, Reuven J. Viskoper, Dror Dicker, & Dov Gavish. (2007). Cost-utility analysis of a national project to reduce hypertension in Israel. Cost Effectiveness and Resource Allocation. 5(1). 16–16. 6 indexed citations

11.

Shargorodsky, Marina, Emily E. Hass, Mona Boaz, Dov Gavish, & Reuven Zimlichman. (2007). High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering. Atherosclerosis. 197(1). 303–310. 14 indexed citations

12.

Shaish, Aviv, Ayelet Harari, Hofit Cohen, et al.. (2006). 9-cis β-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients. Atherosclerosis. 189(1). 215–221. 66 indexed citations

13.

Shargorodsky, Marina, et al.. (2006). The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity. International Journal of Obesity. 30(11). 1632–1638. 33 indexed citations

14.

Leibovitz, Eyal, et al.. (2005). Beyond guidelines: achieving the optimum in LDL cholesterol control. Current Opinion in Lipidology. 16(6). 635–639. 1 indexed citations

15.

Yosefy, Chaim, Gary Ginsberg, Dror Dicker, et al.. (2003). Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program - initial cost utility analysis. Blood Pressure. 12(4). 225–231. 8 indexed citations

16.

Leibovitz, Eyal, Dror Harats, & Dov Gavish. (2002). Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.. PubMed. 4(6). 407–10. 2 indexed citations

17.

Beigel, Yitzhak, Nili Zafrir, Yoram Neuman, et al.. (1995). The Effect of Lovastatin on Early Restenosis. The Journal of Clinical Pharmacology. 35(6). 599–605. 4 indexed citations

18.

Huang, Li‐Shin, Dov Gavish, & Jan L. Breslow. (1990). Sequence polymorphism in the human apoB gene at position 8344. Nucleic Acids Research. 18(19). 5922–5922. 9 indexed citations

19.

Gavish, Dov, Neal Azrolan, & J L Breslow. (1989). Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.. Journal of Clinical Investigation. 84(6). 2021–2027. 137 indexed citations

20.

Fainaru, M, et al.. (1988). Interactions between human and carp (Cyprimus carpio) low density lipoproteins (LDL) and LDL receptors. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 91(2). 331–338. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact